Literature DB >> 34302672

Interface Prediction for GPCR Oligomerization Between Transmembrane Helices.

Wataru Nemoto1,2, Akira Saito3,4.   

Abstract

Oligomers of G protein-coupled receptors (GPCRs) are closely related to their biochemical and biological functions and have been conserved during the course of molecular evolution. The mechanisms of GPCR interactions and the reason why GPCRs interact between themselves have remained elusive. Accurate interface prediction is useful to generate guidelines for mutation and inhibition experiments and would accelerate investigations of the molecular mechanisms of GPCR oligomerization and signaling. We have developed a method to predict the interfaces for GPCR oligomerization. Our method detects clusters of conserved residues along the surfaces of transmembrane helices, using a multiple sequence alignment and a target GPCR or closely related structure. This chapter outlines our method and introduces some problems that occur with it, along with our future direction to extend the method for interface predictions of general membrane proteins.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Conserved residues; Membrane proteins; Transmembrane helices

Mesh:

Substances:

Year:  2021        PMID: 34302672     DOI: 10.1007/978-1-0716-1468-6_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  27 in total

Review 1.  Roles of G-protein-coupled receptor dimerization.

Authors:  Sonia Terrillon; Michel Bouvier
Journal:  EMBO Rep       Date:  2004-01       Impact factor: 8.807

2.  C-terminal interaction is essential for surface trafficking but not for heteromeric assembly of GABA(b) receptors.

Authors:  A Pagano; G Rovelli; J Mosbacher; T Lohmann; B Duthey; D Stauffer; D Ristig; V Schuler; I Meigel; C Lampert; T Stein; L Prezeau; J Blahos; J Pin; W Froestl; R Kuhn; J Heid; K Kaupmann; B Bettler
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

3.  Prediction of interfaces for oligomerizations of G-protein coupled receptors.

Authors:  Wataru Nemoto; Hiroyuki Toh
Journal:  Proteins       Date:  2005-02-15

Review 4.  Membrane interactive alpha-helices in GPCRs as a novel drug target.

Authors:  Wataru Nemoto; Hiroyuki Toh
Journal:  Curr Protein Pept Sci       Date:  2006-12       Impact factor: 3.272

Review 5.  GPCR monomers and oligomers: it takes all kinds.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Trends Neurosci       Date:  2008-01-15       Impact factor: 13.837

Review 6.  G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.

Authors:  Sergi Ferré; Vicent Casadó; Lakshmi A Devi; Marta Filizola; Ralf Jockers; Martin J Lohse; Graeme Milligan; Jean-Philippe Pin; Xavier Guitart
Journal:  Pharmacol Rev       Date:  2014-02-10       Impact factor: 25.468

Review 7.  Dimers and beyond: The functional puzzles of class C GPCRs.

Authors:  Julie Kniazeff; Laurent Prézeau; Philippe Rondard; Jean-Philippe Pin; Cyril Goudet
Journal:  Pharmacol Ther       Date:  2011-01-20       Impact factor: 12.310

8.  Covalent and noncovalent interactions mediate metabotropic glutamate receptor mGlu5 dimerization.

Authors:  C Romano; J K Miller; K Hyrc; S Dikranian; S Mennerick; Y Takeuchi; M P Goldberg; K L O'Malley
Journal:  Mol Pharmacol       Date:  2001-01       Impact factor: 4.436

9.  Single-molecule analysis reveals agonist-specific dimer formation of µ-opioid receptors.

Authors:  Jan Möller; Ali Isbilir; Titiwat Sungkaworn; Brendan Osberg; Christos Karathanasis; Vikram Sunkara; Eugene O Grushevskyi; Andreas Bock; Paolo Annibale; Mike Heilemann; Christof Schütte; Martin J Lohse
Journal:  Nat Chem Biol       Date:  2020-06-15       Impact factor: 16.174

10.  Oligomeric Receptor Complexes and Their Allosteric Receptor-Receptor Interactions in the Plasma Membrane Represent a New Biological Principle for Integration of Signals in the CNS.

Authors:  Dasiel O Borroto-Escuela; Kjell Fuxe
Journal:  Front Mol Neurosci       Date:  2019-09-25       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.